VAERS reports by lot

Pfizer COVID-19 lot ENG206: VAERS reports

30 VAERS reports list lot ENG206 as a Pfizer COVID-19 vaccine, received between 2021-03-06 and 2023-08-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
30
Reports
13%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological3322%
Cardiac / Cardiovascular1812%
Musculoskeletal1712%
General / Systemic (non-local)1712%
Gastrointestinal139%
Respiratory117%
Allergic / Anaphylactic107%
Injection-site / Local reaction96%
Dermatological (non-injection-site)75%
Reproductive / Menstrual64%
Psychiatric / Neuropsychiatric53%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas6
California5
New York4
Pennsylvania2
District of Columbia2
Arizona1
Wisconsin1
Massachusetts1
Washington1
Florida1
Connecticut1
Ohio1

Reports by month received

2021-039
2021-042
2021-052
2021-063
2021-072
2021-082
2021-092
2021-101
2021-111
2022-011
2022-031
2022-072
2022-101
2023-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.